TABLE 1

Clinical and Imaging Scores in Patients with Acute Stroke

Patient no.Age (y)SexBrain territory*99mTc-DTPA ratio99mTc-HMPAO (%)ScoreΔ SInfarct volume (cm3)99mTc-DTPAΔ S <2.5
S1S2>2.5<2.5
170ML MCA11.14019201NA11.1
238FR MCA1247912314012
367ML MCA22.841131633422.8
468ML MCA2.143204222652.122
577FL MCA26.24525272026.2
659FL MCA115304717NA117
773FL MCA15414403515
870ML MCA11213473412134
960MR MCA120254722NA122
1039MR MCA2.552254520122.520
1173ML MCA3.625474921053.6
1265FL MCA6.562131412656.5
1338MR MCA2.23717402302.223
1487FR MCA4.5414402974.5
1545ML MCA5.32580−84045.3
1652FR MCA10.535101339410.5
1750ML MCA3.590108−22683.5
1870FL MCA1239181808712
1953ML MCA3.6NA1212043.6
2074FL MCA9.6NA180−181299.6
2150ML MCA143142713150113
2273MR MCA6.8451612−4NA6.8
2378FR MCA5.2212220−21505.2
2458ML MCA3.11423230NA3.1
2556ML MCA21215147−42421
2677MR MCA150505001010
2767FR MCA5.2NA141621155.2
2873FL MCA3.2329134643.2
2963ML MCA16582618197118
3070MR MCA1158146NA16
  • * Territory of perfusion abnormality.

  • Percentage reduction in perfusion (infarct zone).

  • NA = not applicable.